NanoBase™ vs HLB: The Design Logic That Replaces the 1949 Balance Number

Almost every emulsion on the market today is still governed by a number invented in 1949. If you formulate skincare, you already know it: the Hydrophilic-Lipophilic Balance, or HLB. For three quarters of a century it has done exactly what it was designed to do. The question this page answers is not whether HLB works. It is what HLB was never built to do, and what a brand should reach for when a jar-stable emulsion is no longer enough. The answer is a successor design logic: NanoBase™ Logic. There is now an alternative to HLB logic, and this page makes the case.

What HLB Actually Is (Griffin, 1949)

William Griffin introduced the HLB system in 1949 as a way to predict how a surfactant behaves in an oil and water system. Each surfactant is assigned a single number, on a scale of roughly 0 to 20, that describes how hydrophilic or how lipophilic it is. Match the blended HLB of your emulsifier system to the required HLB of your oil phase, and the two phases stay married in the jar instead of separating on the shelf. That is the whole job. HLB is, at its core, a separation-prevention instrument, and it remains a genuinely useful one.

Credit where it is due. Before Griffin, emulsion design was largely trial and error. HLB gave the industry a shared language and a predictive shortcut. Nothing that follows disputes the physics or the arithmetic. NanoBase™ Logic is not a claim that HLB is wrong. It is a different design convention, built for a goal the 1949 number never had.

HLB Optimizes for the Jar. NanoBase™ Logic Optimizes for the Skin.

Here is the logic-versus-logic distinction in one line. HLB balances a single number to stop oil and water from separating. NanoBase™ Logic engineers the deliberate coexistence of multiple colloidal domains and optimizes for the deposition of their payload. One is tuned for shelf stability. The other is tuned for what happens when the formula meets skin. That doctrine is set out in full on the NanoBase™ Logic page.

The NanoBase™ architecture is a pourable, DLVO-stabilized aqueous system that is itself the continuous phase of your formula. Three domains are engineered to coexist inside it by design: a nanoemulsion domain for lipophilic actives, a nanoliposomal domain for amphiphilic actives and peptides, and a micellar domain for hydrophilic actives. Those three domains are an engineered design decision, and the colloidal terms are defined in the glossary. Dynamic light scattering (DLS) reports size, not structure, so we describe the system honestly: it is DLS-characterized as a multimodal sub-200 nm size distribution, not three morphologies proven by an instrument. Stability is a design principle too, achieved through DLVO and electrostatic stabilization rather than a single balance value.

The Structural Limits of HLB Logic, and the NanoBase™ Inversion

HLB’s limits are not defects. They are the edges of a tool asked to do a job it was never scoped for. Six of them show up again and again on the bench:

• A single balance number. One scalar cannot describe a system meant to carry several classes of active at once. NanoBase™ Logic replaces the number with an architecture, so polarity becomes a routing decision instead of a compromise.
• Payload and active ceilings. Push the active load or mix polarities and an HLB-tuned emulsion tends to destabilize. Three polarity-matched domains give three homes for actives, a structure designed to raise the practical payload ceiling without forcing a re-solve.
• The one-hero-SKU trap. Because re-balancing is costly, HLB pushes brands toward a single optimized emulsion. One architecture instead supports a whole family of finished formulas built on the same continuous phase.
• Coarse droplets that stay on the surface. Macro-scale droplets tend to sit as a film and rinse away before they deliver. NanoBase™ Logic is designed around sub-200 nm carriers instead. Third-party literature on sub-200 nm systems associates finer particle scale with more efficient deposition and bioavailability at the skin surface, which is the design rationale here rather than a measured NanoBase™ result, and it points to deposition, not transdermal penetration.
• Every new active means re-balancing. In HLB, adding an ingredient shifts the required balance and forces reformulation. With NanoBase™ Logic, you dose an active into the domain that matches its polarity while the continuous phase stays put.
• Usually a hot process. Classic emulsification heats both phases and holds them. The finished formula you build on the architecture cold-processes at any qualified contract manufacturer on standard equipment.

One point of discipline matters here. Pensive Beauty® manufactures the NanoBase™ architecture and ships it as a finished raw material. Your team does not make or run the architecture; you formulate on top of it, adding your actives, fragrance, and sensory into a system that has already done the colloidal engineering. The cold-processable step is that finished formula, not the architecture underneath it.

HLB vs NanoBase™ Logic, Side by Side

Why the Migration Is Already Underway

For a brand, the difference is strategic, not academic. HLB logic quietly caps what a product line can become: one hero emulsion, a bounded active load, a reformulation project every time R&D wants to add the next ingredient, and a delivery profile that leaves much of the payload sitting on the surface. NanoBase™ Logic inverts each of those constraints at once, which is why the shift is already underway. To our knowledge, NanoBase™ is the only commercially available raw material built to this tri-domain convention rather than to a single balance number, and we frame that as a design convention, not a claim about physics.

The architecture is in use with tier-1 global manufacturers and independent brands alike, the partners who care most about payload, range velocity, and speed to launch. NANOBASE is the subject of a US trademark application in Class 001 with first commercial use in 2025, and the framework has been adopted into the EVCC Medical Aesthetics Certificate Program, effective 2027, as part of how the next generation of formulators is taught. The measurement discipline behind the architecture, including its DLS characterization as a multimodal sub-200 nm size distribution, is documented in our open preprints on Zenodo, at https://zenodo.org/records/21971474 and https://zenodo.org/records/18616576, and summarized on the research and evidence page.

NanoBase™ ships as an empty chassis. It carries no actives and makes no clinical claim of its own; your formula, your actives, and your positioning ride on top of it. That is the point. The architecture does the nanoscience so your bench can spend its time on the product. See how a finished formula comes together in the skincare formulation lab, built and supported by a boutique nanoscience lab and a 10,000 sq ft production facility.

Move Beyond the 1949 Number

If your range has hit an HLB ceiling, the fastest way to feel the difference is to build on the architecture yourself. Request a sample and spec sheet to formulate on the tri-domain system at your own bench, or hand your brief to the free AI Chemist and watch a multi-domain formula route your actives by polarity in minutes. HLB taught the industry how to stop separation. NanoBase™ Logic teaches it how to build.